Get 20% Free Customization In This Report

Buy this report from - $3456

Point of Care Test Market by Application (Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Blood Gas & Electrolyte Testing, Pregnancy & Fertility Testing, Tumour Markers Testing, Cholesterol Testing and Urinalysis) and by End Users (Hospitals, Diagnostics Centres and Others) - Europe Opportunity Analysis and Industry Forecast 2017-2023

Medical Devices & Supplies	LI_183779	Pages: NA	Jun 2018 \| 601 Views
Author's : NA	Tables: NA	Charts: NA	Formats*:

Point of care test or POCT is the diagnostics test done with the help of electronic and non-electronic devices. It replaces several laboratory and clinical experiments, hence decrease the turnaround time required for the tests. The prime factors that drive the market growth are the rise in demand for POCT among patients, increase in the disposable income and rapid increase in medical tourism in Europe. However, lack of awareness about POC tests restraint the market growth. Moreover, increasing technological developments in the field of POC tests will offer lucrative opportunities for the market growth.

The report segments the market on the basis of applications, end users and countries. Based on application, the market is segmented into blood glucose testing, infectious diseases testing, cardiac markers testing, coagulation testing, blood gas and electrolyte testing, pregnancy and fertility testing, tumour markers testing, cholesterol testing and urinalysis. Based on end users, then market is segmented into hospitals, diagnostics centres and others. Based on country, the market is segmented in France, U.K, Italy, Spain, Germany and rest of Europe.

The key players of the market are Alere, F Hoffmann La Roche Ltd., Abbott Laboratories, Lifescan Inc., Becton, Dickenson and Company (BD), Affymetrix Inc. (ThermoFisher Scientific Inc.), Agilent Technologies, Danaher Corporation, BioMerieux S.A and Nova Biomedical.

Key Benefits

The study provides an in-depth analysis of the point of care test market along with the current trends and future estimations to elucidate the imminent investment pockets.
Comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
Comprehensive quantitative analysis of the industry is provided for the period of 20162023 to assist stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the key segments of the industry helps in understanding the trends in types of point of care test across Europe.
Key market players and their strategies have been provided to understand the competitive outlook of the industry.

Point Of Care Test Market Key Segments:

By Application

Blood Glucose Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Blood Gas & Electrolyte Testing
Pregnancy & Fertility Testing
Tumor Markers Testing
Cholesterol Testing
Urinalysis

By End Users

Hospitals
Diagnostics Centers
Others

By Country

UK
France
Germany
Italy
Spain
Rest of Europe

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING, 2016
3.4.PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
356.3. Opportunities

Chapter: 4 EUROPE POINT OF CARE TEST MARKET, BY APPLICATIONS

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. BLOOD GLUCOSE TESTING

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. INFECTIOUS DISEASE TESTING

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. CARDIAC MARKER TESTING

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

4.5. COAGULATION TESTING

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast

4.6. BLOOD GAS & ELECTROLYTE TESTING

4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast

4.7. PREGNANCY & FERTILITY TESTING

4.7.1. Key market trends
4.7.2. Growth factors and opportunities
4.7.3. Market size and forecast

4.8. TUMOR MARKER TESTING

4.8.1. Key market trends
4.8.2. Growth factors and opportunities
4.8.3. Market size and forecast

4.9. CHOLESTEROL TESTING

4.9.1. Key market trends
4.9.2. Growth factors and opportunities
4.9.3. Market size and forecast

4.10. URINALYSIS

4.10.1. Key market trends
4.10.2. Growth factors and opportunities
4.10.3. Market size and forecast

Chapter: 5 EUROPE POINT OF CARE TEST MARKET, BY END USERS

5.1. OVERVIEW

4.1.1. Market size and forecast

5.2. HOSPITALS

5.2.1. Key market trends
5.2.2. Growth factors and opportunities
5.2.3. Market size and forecast

5.3. DIAGNOSTIC CENTRES

5.3.1. Key market trends
5.3.2. Growth factors and opportunities
5.3.3. Market Size And Forecast

5.4. OTHERS

5.4.1. Key market trends
5.4.2. Growth factors and opportunities
5.4.3. Market Size And Forecast

Chapter: 6 EUROPE POINT OF CARE MARKET, BY REGION

6.1. EUROPE

6.1.1. Key market trends
6.1.2. Key growth factors and opportunities
6.1.3. Market size and forecast

6.1.3.1. Germany market size and forecast
6.1.3.2. France market size and forecast
6.1.3.3. UK market size and forecast
6.1.3.4. Italy market size and forecast
6.1.3.5. Spain market size and forecast
6.1.3.6. Rest of Europe market size and forecast

6.1.5. Europe Point of Care Testing Market by Methods
6.1.4. Europe Point of Care Testing Market by End Users

Chapter: 7 COMPANY PROFILES

7.1. ABBOTT LABORATORIES

7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments

7.2. ALIGENT TECHNOLOGIES

7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments

7.3. F. HOFFMANN LA ROCHE LTD

7.3.1. Operating Business Segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments

7.4. AFFYMETRIX INC. (THERMOFISCHER SCIENTIFIC INC.)

7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments

7.5. ALERE

7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments

7.6. LIFESCAN INC.

7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments

7.7. BECTON, DICKENSON AND COMPANY (BD)

7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments

7.8. DANAHAR CORPORATION

7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments

7.9. BIOMERIEUX S.A

7.9.1. Operating Business Segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments

7.10. NOVA BIOMEDICAL

7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.